Status:
NOT_YET_RECRUITING
Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy
Lead Sponsor:
Qilu Hospital of Shandong University
Conditions:
Esophagus Cancer
Esophagectomy
Eligibility:
All Genders
Brief Summary
To analyze and compare the long-term recurrence-free survival rate, overall survival rate and quality of survival after minimally invasive esophagectomy and open esophagectomy, and to conduct subgroup...
Detailed Description
1. Purpose of the study To study the differences in long-term disease-free survival rate and overall survival rate after minimally invasive esophagectomy and open esophagectomy, as well as postoperati...
Eligibility Criteria
Inclusion
- Patients who had undergone esophageal cancer resection at the Department of Thoracic Surgery, Qilu Hospital, Shandong University, between 2013 and 2021, with pathology results confirming esophageal squamous carcinoma, adenocarcinoma, or other malignant tumors.
- The surgery was successfully completed, the patient was safely discharged from the hospital, the postoperative follow-up was successful, and if the follow-up patient died, his or her death was due to natural causes.
Exclusion
- Perioperative patient deaths, pathologic findings other than those listed above, loss of visits, and postoperative unnatural deaths.
Key Trial Info
Start Date :
November 27 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
1474 Patients enrolled
Trial Details
Trial ID
NCT06147180
Start Date
November 27 2023
End Date
August 31 2026
Last Update
November 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital of Shandong University
Ji'nan, Shandong, China, 250012